←Back to Expert Scholars
Translational Medicine / 转化医学Ewing Sarcoma, Pediatric Phase 1
Steven DuBois
MD, MS
🏢Dana Farber Boston Children's Cancer Center🌐USA
Director Experimental Therapeutics
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Steven DuBois directs experimental therapeutics for pediatric solid tumors including Ewing sarcoma at Dana Farber Boston Children's. He has led phase 1 and 2 trials of IGF1R inhibitors and novel agents in Ewing sarcoma. His work advances early phase clinical trials in pediatric oncology.
Share:
🧪Research Fields 研究领域
Ewing sarcoma
pediatric phase 1
experimental therapeutics
IGF1R inhibitors
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Steven DuBois 的研究动态
Follow Steven DuBois's research updates
留下邮箱，当我们发布与 Steven DuBois（Dana Farber Boston Children's Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment